PYGL and head and neck squamous cell carcinoma: As mentioned earlier, METArisk phenotype related to cell metabolism reprogramming was potential to classify inter-patient heterogeneity and clinical outcomes in HNSCC; hence we next sought to identify the metabolic characteristics that attributed to poor prognosis and correlated with PYGL’s expression.